118 related articles for article (PubMed ID: 11849755)
1. Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains.
Ghebremedhin E; Thal DR; Schultz C; Braak H
Neurosci Lett; 2002 Mar; 320(1-2):25-8. PubMed ID: 11849755
[TBL] [Abstract][Full Text] [Related]
2. Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages.
Ghebremedhin E; Thal DR; Schultz C; Braak H; Deller T
Acta Neuropathol; 2007 Oct; 114(4):359-63. PubMed ID: 17701416
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
[TBL] [Abstract][Full Text] [Related]
5. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.
Singleton AB; Smith G; Gibson AM; Woodward R; Perry RH; Ince PG; Edwardson JA; Morris CM
Hum Mol Genet; 1998 May; 7(5):937-9. PubMed ID: 9536100
[TBL] [Abstract][Full Text] [Related]
6. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
7. Association between butyrylcholinesterase K variant and the Alzheimer type neuropathological changes in apolipoprotein E epsilon4 carriers older than 75 years.
Sodeyama N; Yamada M; Itoh Y; Otomo E; Suematsu N; Matsushita M
J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):693-4. PubMed ID: 10577037
[No Abstract] [Full Text] [Related]
8. Butyrylcholinesterase K variant and cerebral amyloid angiopathy.
Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H
Stroke; 1998 Dec; 29(12):2488-90. PubMed ID: 9836756
[TBL] [Abstract][Full Text] [Related]
9. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
Wiebusch H; Poirier J; Sévigny P; Schappert K
Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327
[TBL] [Abstract][Full Text] [Related]
10. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
Lehmann DJ; Johnston C; Smith AD
Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease.
Brindle N; Song Y; Rogaeva E; Premkumar S; Levesque G; Yu G; Ikeda M; Nishimura M; Paterson A; Sorbi S; Duara R; Farrer L; St George-Hyslop P
Hum Mol Genet; 1998 May; 7(5):933-5. PubMed ID: 9536099
[TBL] [Abstract][Full Text] [Related]
12. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
[TBL] [Abstract][Full Text] [Related]
13. The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.
Kehoe PG; Williams H; Holmans P; Wilcock G; Cairns NJ; Neal J; Owen MJ
J Med Genet; 1998 Dec; 35(12):1034-5. PubMed ID: 9863603
[TBL] [Abstract][Full Text] [Related]
14. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
[TBL] [Abstract][Full Text] [Related]
15. The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.
Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Viadero C; Peña N
Acta Neurol Scand; 2000 Dec; 102(6):350-3. PubMed ID: 11125748
[TBL] [Abstract][Full Text] [Related]
16. Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles.
Kazama H; Ruberu NN; Murayama S; Saito Y; Nakahara K; Kanemaru K; Nagura H; Arai T; Sawabe M; Yamanouchi H; Orimo H; Hosoi T
Dement Geriatr Cogn Disord; 2004; 18(2):145-50. PubMed ID: 15211069
[TBL] [Abstract][Full Text] [Related]
17. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
18. No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese.
Lee DW; Liu HC; Liu TY; Chi CW; Hong CJ
Am J Med Genet; 2000 Apr; 96(2):167-9. PubMed ID: 10893490
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.
Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N
Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954
[TBL] [Abstract][Full Text] [Related]
20. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
